ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryCarouge GeAgeronix SA
Ageronix SA Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Ageronix's core activity is the development of treatments for neurodegenerative diseases, particularly using the protein Alpha 1 Anti-Trypsin (AAT). The company focuses on researching and developing therapies for rare neurological disorders, such as Charcot-Marie-Tooth disease (CMT), and has already completed preclinical developments and plans to initiate clinical trials in 2024.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered3
Development of therapies for neurological diseases
Preclinical and clinical development of alpha-1 antitrypsin–based therapies for neurological diseases, in particular Charcot-Marie-Tooth disease.
Research on alpha-1 antitrypsin therapies
Research into the therapeutic use of alpha-1 antitrypsin, including human and recombinant AAT for inflammatory and neurodegenerative diseases.
Development of therapies for Charcot-Marie-Tooth disease
Development of a new treatment candidate for Charcot-Marie-Tooth disease, including preclinical development, FDA Orphan Drug Designation, and clinical trial phase.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Ageronix SA

Trust & reputation

ranQ Trust Score of Ageronix SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Ageronix SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Ageronix SA scores 83.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.95.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Ageronix SA scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Ageronix SA scores 1.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.1.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Ageronix SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Ageronix SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Ageronix SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Ageronix SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Ageronix SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Rue du Tir-au-Canon 4
1227 Carouge Ge

At a glance

Legal form
Corporation
UID
CHE-208.392.325
Founded
2013 · 13 years
Last commercial register change
July 8, 2022
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AP
    Addex Pharma SA
    Plan-Les-Ouates
    KK
    Kyowa Kirin Sàrl
    Geneva
    AT
    Atopia Therapeutics SA
    Geneva
    CR
    CELL RECEPTOR SA
    Geneva
    MM
    MMV MEDICINES FOR MALARIA VENTURE
    Cointrin
    TP
    Telix Pharmaceuticals (Switzerland) Sàrl
    Petit-Lancy
    GS
    Gliapharm SA
    Geneva
    RF
    ReMedys Foundation
    Geneva